Synergistic Effects of Caffeine in Combination with Conventional Drugs: Perspectives of a Drug That Never Ages
暂无分享,去创建一个
R. Di Santo | R. Costi | V. N. Madia | Davide Ialongo | V. Tudino | A. Messore | E. Patacchini | M. Arpacioglu
[1] J. Piosik,et al. New Life of an Old Drug: Caffeine as a Modulator of Antibacterial Activity of Commonly Used Antibiotics , 2022, Pharmaceuticals.
[2] K. Dzobo,et al. The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery , 2021, Reference Module in Biomedical Sciences.
[3] M. Aboutabl,et al. Simultaneous administration of coffee and rasagiline/l-dopa protects against paraquat-induced neurochemical and motor behavior impairments in vivo , 2021, Bulletin of the National Research Centre.
[4] Giuseppe Faudone,et al. The Medicinal Chemistry of Caffeine. , 2021, Journal of medicinal chemistry.
[5] A. Alshabi,et al. Caffeine modulates pharmacokinetic and pharmacodynamic profiles of pioglitazone in diabetic rats , 2021, Saudi medical journal.
[6] M. Morelli,et al. Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists , 2021, Handbook of Neurotoxicity.
[7] M. Diaz,et al. PLANT EXTRACTS DISPLAY SYNERGISM WITH DIFFERENT CLASSES OF ANTIBIOTICS , 2021, Biologia: Ensino, Pesquisa e Extensão - Uma Abordagem do Conhecimento Científico nas Diferentes Esferas do Saber.
[8] M. Kim,et al. Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer’s and Parkinson’s Disease: Insight into the Role of Nrf-2 and A2AR Signaling , 2020, Antioxidants.
[9] C. Bai,et al. The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis , 2020, Nutrients.
[10] K. Jacobson,et al. Adenosine A2A receptor antagonists: from caffeine to selective non‐xanthines , 2020, British journal of pharmacology.
[11] Zhilei Wang,et al. Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma , 2019, Medical Oncology.
[12] P. Sengupta,et al. Edaravone-caffeine combination for the effective management of rotenone induced Parkinson’s disease in rats: An evidence based affirmative from a comparative analysis of behavior and biomarker expression , 2019, Neuroscience Letters.
[13] N. Yamamoto,et al. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo , 2019, BMC Cancer.
[14] Priscilla A DA Costa,et al. Plant Extracts Display Synergism with Different Classes of Antibiotics. , 2019, Anais da Academia Brasileira de Ciencias.
[15] B. Salehi,et al. Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective , 2019, Medicina.
[16] T. Weiser,et al. Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I Study , 2019, Advances in Therapy.
[17] P. Agostinho,et al. Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease , 2018, Neurobiology of Disease.
[18] I. Gordo,et al. Evolutionary Mechanisms Shaping the Maintenance of Antibiotic Resistance. , 2018, Trends in microbiology.
[19] S. Antollini,et al. A novel pharmacological activity of caffeine in the cholinergic system , 2018, Neuropharmacology.
[20] D. Miljkovic,et al. Caffeine induces metformin anticancer effect on fibrosarcoma in hamsters. , 2018, European review for medical and pharmacological sciences.
[21] A. Nehlig. Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption , 2018, Pharmacological Reviews.
[22] R. Cunha,et al. Chronic coffee consumption and respiratory disease: A systematic review , 2018, The clinical respiratory journal.
[23] M. Hidaka,et al. Caffeine Has a Synergistic Anticancer Effect with Cisplatin via Inhibiting Fanconi Anemia Group D2 Protein Monoubiquitination in Hepatocellular Carcinoma Cells. , 2017, Biological & pharmaceutical bulletin.
[24] R. Lipton,et al. Caffeine in the management of patients with headache , 2017, The Journal of Headache and Pain.
[25] Richard E. Harris,et al. Caffeine as an opioid analgesic adjuvant in fibromyalgia , 2017, Journal of pain research.
[26] V. Giaccone,et al. Antimicrobial resistance: A global emerging threat to public health systems , 2017, Critical reviews in food science and nutrition.
[27] Julie Brown,et al. Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.
[28] N. Yamamoto,et al. Non-toxic Efficacy of the Combination of Caffeine and Valproic Acid on Human Osteosarcoma Cells In Vitro and in Orthotopic Nude-mouse Models. , 2016, Anticancer research.
[29] M. Gharghabi,et al. The Effect of Caffeine and chk2 Inhibitor on Doxorubicin-Induced Cellular Senescence in MCF-7 Cells , 2016, Drug Research.
[30] Andrew P. Smith,et al. Caffeine: Friend or Foe? , 2016, Annual review of food science and technology.
[31] L. Price,et al. Animal production and antimicrobial resistance in the clinic , 2016, The Lancet.
[32] E. Eichenwald. Apnea of Prematurity , 2016, Pediatrics.
[33] A. Al-majed,et al. Chapter Five – Pioglitazone , 2016 .
[34] R. D'Hooge,et al. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy , 2016, Molecular Psychiatry.
[35] M. Diederich,et al. Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer , 2015, Genes & Nutrition.
[36] F. Greenway,et al. The effect of caffeine and albuterol on body composition and metabolic rate , 2015, Obesity.
[37] Michael Wink,et al. Modes of Action of Herbal Medicines and Plant Secondary Metabolites , 2015, Medicines.
[38] S. Bruno,et al. Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells , 2015, Oncotarget.
[39] J. Haber,et al. Caffeine inhibits gene conversion by displacing Rad51 from ssDNA , 2015, Nucleic acids research.
[40] Mickael Guedj,et al. Analysis of drug combinations: current methodological landscape , 2015, Pharmacology research & perspectives.
[41] T. Miyazaki,et al. Development of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles , 2015, Oncology reports.
[42] U. Kadam,et al. Multi-drug therapy in chronic condition multimorbidity: a systematic review. , 2014, Family practice.
[43] E. Poleszak,et al. Review on analgesic effect of co-administrated ibuprofen and caffeine , 2014 .
[44] M. Kamal,et al. Hepatoprotective Effects of Silybum marianum (Silymarin) and Glycyrrhiza glabra (Glycyrrhizin) in Combination: A Possible Synergy , 2014, Evidence-based complementary and alternative medicine : eCAM.
[45] R. Kazmierkiewicz,et al. Caffeine and other methylxanthines as interceptors of food-borne aromatic mutagens: inhibition of Trp-P-1 and Trp-P-2 mutagenic activity. , 2013, Chemical research in toxicology.
[46] Y. Okamura,et al. Evaluation of anticancer effects and enhanced doxorubicin cytotoxicity of xanthine derivatives using canine hemangiosarcoma cell lines. , 2013, Research in veterinary science.
[47] S. Oh,et al. Caffeine as an adjuvant therapy to opioids in cancer pain: a randomized, double-blind, placebo-controlled trial. , 2013, Journal of pain and symptom management.
[48] J. Piosik,et al. Modulation of acridine mutagen ICR191 intercalation to DNA by methylxanthines--analysis with mathematical models. , 2013, Bioorganic & medicinal chemistry.
[49] M. I. Díaz-Reval,et al. Opioid Mechanism Involvement in the Synergism Produced by the Combination of Diclofenac and Caffeine in the Formalin Model , 2013, ISRN Pain.
[50] B. Kramer,et al. Synergistic Effect of Caffeine and Glucocorticoids on Expression of Surfactant Protein B (SP-B) mRNA , 2012, PloS one.
[51] O. Obodozie. Pharmacokinetics and Drug Interactions of Herbal Medicines: A Missing Critical Step in the Phytomedicine/Drug Development Process , 2012 .
[52] Shwu-Huey Liu,et al. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. , 2012, Journal of ethnopharmacology.
[53] Tina Manzhu Kang,et al. The Aminoglycoside Antibiotic Kanamycin Damages DNA Bases in Escherichia coli: Caffeine Potentiates the DNA-Damaging Effects of Kanamycin while Suppressing Cell Killing by Ciprofloxacin in Escherichia coli and Bacillus anthracis , 2012, Antimicrobial Agents and Chemotherapy.
[54] David J Newman,et al. Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.
[55] A. Izzo. Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data , 2012, Medical Principles and Practice.
[56] D. M. Robinson,et al. Pioglitazone , 2012, Drugs.
[57] A. Bode,et al. Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. , 2011, Carcinogenesis.
[58] K. Audenaert,et al. Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease , 2011, International journal of Alzheimer's disease.
[59] J. Sawynok. Caffeine and pain , 2011, PAIN®.
[60] H. Ke,et al. Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds. , 2011, Handbook of experimental pharmacology.
[61] David J Henderson-Smart,et al. Methylxanthine treatment for apnoea in preterm infants. , 2010, The Cochrane database of systematic reviews.
[62] M. González-Trujano,et al. Tramadol and caffeine produce synergistic interactions on antinociception measured in a formalin model , 2010, Pharmacology Biochemistry and Behavior.
[63] Y. Hwang,et al. Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase‐9 activation through a calcium and protein kinase Cα‐dependent pathway: phorbol‐12‐myristate‐13‐acetate‐induced/extracellular signal‐regulated kinase/activator protein‐1 , 2010, British journal of pharmacology.
[64] R. Holley,et al. Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria. , 2010, International journal of food microbiology.
[65] D. Newman,et al. Impact of natural products on developing new anti-cancer agents. , 2009, Chemical reviews.
[66] V. Echeverria,et al. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. , 2009, Journal of Alzheimer's disease : JAD.
[67] M. Wink. Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine. , 2008, Current drug metabolism.
[68] M. Doble,et al. Synergism between natural products and antibiotics against infectious diseases. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[69] Chukwuma O. Agubata,et al. In vitro interaction between caffeine and some penicillin antibiotics against Staphylococcus aureus , 2008 .
[70] B. Schmidt,et al. Evidence-Based Neonatal Drug Therapy for Prevention of Bronchopulmonary Dysplasia in Very-Low-Birth-Weight Infants , 2008, Neonatology.
[71] Masami Kawahara,et al. The antitumor effect of liposome-encapsulated cisplatin on rat osteosarcoma and its enhancement by caffeine. , 2008, Anticancer research.
[72] G. Castañeda-Hernández,et al. Examination of the interaction between peripheral lumiracoxib and opioids on the 1% formalin test in rats , 2008, European journal of pain.
[73] F. López-Muñoz,et al. Sinergismo de la cafeína sobre los efectos antinociceptivos del metamizol , 2008 .
[74] R. Shapiro. Caffeine and headaches , 2008, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.
[75] A. Nissinen,et al. Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study , 2007, European Journal of Clinical Nutrition.
[76] D. Souza,et al. Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25–35)-induced cognitive deficits in mice , 2007, Experimental Neurology.
[77] L. Zacharia,et al. Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production , 2006, Neuroscience.
[78] Ted Powers,et al. Caffeine Targets TOR Complex I and Provides Evidence for a Regulatory Link between the FRB and Kinase Domains of Tor1p* , 2006, Journal of Biological Chemistry.
[79] P. Imming,et al. Drugs, their targets and the nature and number of drug targets , 2006, Nature Reviews Drug Discovery.
[80] L. D. Di Stasi,et al. Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. , 2006, Memorias do Instituto Oswaldo Cruz.
[81] Jesper Bo Nielsen,et al. Interactions of skin thickness and physicochemical properties of test compounds in percutaneous penetration studies , 2006, International archives of occupational and environmental health.
[82] S. Ibrahim,et al. Application of caffeine, 1,3,7-trimethylxanthine, to control Escherichia coli O157:H7 , 2006 .
[83] H. Diener,et al. The Fixed Combination of Acetylsalicylic acid, Paracetamol and Caffeine is more Effective than Single Substances and Dual Combination for the Treatment of Headache: a Multicentre, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Parallel Group Study , 2005, Cephalalgia : an international journal of headache.
[84] J. Piosik,et al. Formation of stacking complexes between caffeine (1,2,3-trimethylxanthine) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine may attenuate biological effects of this neurotoxin. , 2005, Bioorganic chemistry.
[85] J. Grutsch,et al. The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care , 2005, Supportive Care in Cancer.
[86] E. Bastia,et al. Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease. , 2005, Pharmacology & therapeutics.
[87] Weiya Ma,et al. Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells. , 2004, Cancer research.
[88] D. Shi,et al. Caffeine Analogs: Effects on Ryanodine-Sensitive Calcium-Release Channels and GABAA Receptors , 2003, Cellular and Molecular Neurobiology.
[89] T. Aburjai,et al. Screening of antibiotic resistant inhibitors from local plant materials against two different strains of Staphylococcus aureus. , 2002, Journal of ethnopharmacology.
[90] F. Greenway. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[91] S. Mercadante,et al. Effects of caffeine as an adjuvant to morphine in advanced cancer patients. A randomized, double-blind, placebo-controlled, crossover study. , 2001, Journal of pain and symptom management.
[92] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[93] A. Nahrstedt,et al. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. , 2000, Planta medica.
[94] G. G. Nascimento,et al. Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria , 2000 .
[95] F. Sarkar,et al. Molecular effects of taxol and caffeine on pancreatic cancer cells. , 1999, International journal of molecular medicine.
[96] G. Castañeda-Hernández,et al. A review of the pharmacokinetic and pharmacodynamic factors in the potentiation of the antinociceptive effect of nonsteroidal anti-inflammatory drugs by caffeine. , 1999, Journal of pharmacological and toxicological methods.
[97] S. Amin,et al. Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. , 1998, Cancer research.
[98] N. Yamamoto,et al. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma. , 1998, Anticancer research.
[99] J. Sawynok. Adenosine receptor activation and nociception. , 1998, European journal of pharmacology.
[100] G. Engelhardt,et al. Role of caffeine in combined analgesic drugs from the point of view of experimental pharmacology. , 1997, Arzneimittel-Forschung.
[101] J. Sawynok,et al. Caffeine antinociception: role of formalin concentration and adenosine A1 and A2 receptors. , 1996, European journal of pharmacology.
[102] F. López-Muñoz,et al. Potentiation by caffeine of the analgesic effect of aspirin in the pain-induced functional impairment model in the rat. , 1994, Canadian journal of physiology and pharmacology.
[103] V. Anttila,et al. Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[104] V. Granados-Soto,et al. Characterization of the Analgesic Effects of Paracetamol and Caffeine Combinations in the Pain‐induced Functional Impairment Model in the Rat , 1993, The Journal of pharmacy and pharmacology.
[105] T. Yaksh,et al. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. , 1993, Pharmacological reviews.
[106] G. Pöch. Synergism/potentiation and antagonism — phenomena and mechanisms , 1993 .
[107] Dr. Gerald Pöch. Combined Effects of Drugs and Toxic Agents , 1993, Springer Vienna.
[108] P. Pandhi,et al. Determination of the optimal analgesia-potentiating dose of caffeine and a study of its effect on the pharmacokinetics of aspirin in mice. , 1991, Methods and findings in experimental and clinical pharmacology.
[109] Clara Franzini-Armstrong,et al. The brain ryanodine receptor: A caffeine-sensitive calcium release channel , 1991, Neuron.
[110] S. Toubro,et al. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study. , 1991, Metabolism: clinical and experimental.
[111] T. Shimamura,et al. [Antifungal and fungicidal activities of tea extract and catechin against Trichophyton]. , 1991, Nihon saikingaku zasshi. Japanese journal of bacteriology.
[112] H. Tsuchiya,et al. Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma. , 1989, Clinical therapeutics.
[113] M. Berenbaum. What is synergy? , 1989, Pharmacological reviews.
[114] A. Misra,et al. Potentiation of morphine analgesia by caffeine , 1985, British journal of pharmacology.
[115] Roberts Jj. Mechanism of potentiation by caffeine of genotoxic damage induced by physical and chemical agents. , 1984 .
[116] R. S. Da Silva,et al. Caffeine , 1984, Springer Berlin Heidelberg.
[117] Daniel M. Togasaki,et al. Caffeine stimulates β-endorphin release in blood but not in cerebrospinal fluid , 1982 .
[118] K Fuxe,et al. Effects of caffeine on central monoamine neurons , 1972, The Journal of pharmacy and pharmacology.
[119] B A Berkowitz,et al. Release of norepinephrine in the central nervous system by theophylline and caffeine. , 1970, European journal of pharmacology.
[120] H VELDSTRA,et al. Synergism and potentiation with special reference to the combination of structural analogues. , 1956, Pharmacological reviews.